Dimethyl Fumarate Capsule, Delayed Release
Product Images NDC 67877-555

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dimethyl Fumarate (NDC 67877-555). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dmf-120mg-14s (Dmf 120mg 14s)

Dimethyl Fumarate 120 mg delayed-release capsules label showing a 14-capsule count. The label states oral use with instructions to swallow capsules whole. Manufactured by Alkem Laboratories Ltd., India, and distributed by Ascend Laboratories, LLC, Parsippany, NJ. Includes storage instructions and a barcode with NDC 67877-555-14.*

FDA Label Image

Dmf-240mg-60s (Dmf 240mg 60s)

Dimethyl Fumarate 240 mg Delayed-Release Capsules label showing dosage form as oral capsules in a package of 60. The label includes directions to swallow the capsule whole, storage instructions, Rx only status, manufacturer Alkem Laboratories Ltd., Mumbai, India, and distributor Ascend Laboratories, LLC, Parsippany, NJ. The label features a barcode and identifies the product as containing 240 mg dimethyl fumarate per capsule.*

FDA Label Image

Dmf-f1 (Dmf F1)

Chemical structure of dimethyl fumarate, showing the molecular arrangement of atoms and double bonds characteristic of this compound.*

FDA Label Image

Dmf-f2 (Dmf F2)

A line graph showing the percentage of subjects with confirmed progression of disability over 96 weeks comparing Dimethyl fumarate delayed release capsules 240 mg BID with placebo. The x-axis represents time on study in weeks, and the y-axis shows the percentage of subjects with confirmed progression of disability. The graph indicates lower progression percentages for the Dimethyl fumarate group compared to placebo at study end.*

FDA Label Image

Dmg-outer-carton (Dmf Outer Carton)

Box label for Dimethyl Fumarate delayed-release capsules 120 mg and 240 mg, a 30-day starter pack by Ascend Laboratories, LLC. The package contains one bottle of 14 capsules (120 mg) and one bottle of 46 capsules (240 mg). Instructions specify using the 120 mg dose for days 1 to 7 and the 240 mg dose for days 8 to 30, with capsules to be swallowed whole. The label includes storage and dosing notes and manufacturer information from Alkem Laboratories Ltd.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.